Status:

COMPLETED

Fatigue As a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?

Lead Sponsor:

Kristiania University College

Collaborating Sponsors:

Norwegian Cancer Society

University of Bergen

Conditions:

Fatigue

Depression, Anxiety

Eligibility:

FEMALE

18-80 years

Phase:

NA

Brief Summary

The success of treatment of breast cancer has improved, hence the prevalence of survivors have increased. However, experienced late effects from the cancer itself or from cancer treatment is substanti...

Detailed Description

Introduction Breast cancer is the most common tumour type in women worldwide. The success of the treatment of breast cancer have improved hence the prevalence of survivors have increased (American Can...

Eligibility Criteria

Inclusion

  • Breast cancer survivors, aged 18 or older, not receiving any curative cancer treatment
  • Fatigue score on a VAS scale ≥4 will be eligible
  • Sufficient knowledge of Norwegian is necessary for communicating with the acupuncturist and for filling in and understanding all the Norwegian questionnaires within the study.
  • Participants who have freely agreed to take part in the study and have signed an informed consent form.

Exclusion

  • Any causal pathology related to fatigue or receiving ongoing acupuncture treatment for fatigue.
  • Participants who are pregnant at baseline or planning to get pregnant within the treatment period will be excluded. Reason is that several acupuncture points should be avoided during pregnancy and several of those are related to the treatment of fatigue.
  • Potential participants who are unable to understand, speak, or who find it difficult to communicate in Norwegian will be excluded from the study.
  • Individuals presenting with clinically diagnosed conditions or pathologies known to contribute to fatigue and persons whose fatigue could be attributed to pre-existing conditions

Key Trial Info

Start Date :

September 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2024

Estimated Enrollment :

223 Patients enrolled

Trial Details

Trial ID

NCT04418115

Start Date

September 1 2021

End Date

December 31 2024

Last Update

March 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kristiania University College

Oslo, Norway, 0107